PROS1 and COVID-19: In our previous work [29], covalent immobilization of the SARS-CoV-2 S-protein and its affinity interaction with specific antibodies against SARS-CoV-2 virus proteins in blood serum patient samples after coronavirus disease 2019 (COVID-19) (anti-rSpike) were evaluated.